Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 14 min ago
Peer-reviewedLicence not statedJournal of Nuclear Medicine

Optimizing the Therapeutic Index: Sequential Intraarterial–Intravenous PRRT with Personalized Volumetric-Adjusted Dosing

  • Lisa Bodei1,2
  • Etay Ziv2,3
  • Audrey Mauguen4
  • Pat Zanzonico5
  • Diane Reidy6
  • Adrian Gonzalez-Aguirre3
  • Bae Chu5
  • Jonathan Kuten1
  • Nitya Raj6
  • Heiko Schöder1,2
  • Joseph A. O’Donoghue5
6 affiliations
  1. 1Molecular Imaging and Therapy, Memorial Sloan Kettering Cancer Center, New York, New York
  2. 2Department of Radiology, Weill Cornell Medical College of Cornell University, New York, New York
  3. 3Interventional Radiology Services, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  4. 4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
  5. 5Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; and
  6. 6Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
Read full textDOICite

Related

  1. Personalized prediction of sequential therapeutic responses in HR+/HER2-low breast cancer using patient-derived organoids
    Wei Zhao, Zhongni Wu, Chengpan Li +13
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Multimodal predictors of response to intravenous ketamine in treatment-resistant depression: toward personalized treatment in major depressive and bipolar disorders
    Magda Malewska-Kasprzak, Filip Rybakowski, Monika Dmitrzak-Weglarz
    CNS SpectrumsPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMC
  3. Optimizing intravenous amoxicillin for outpatient parenteral antimicrobial therapy
    Zenaw Wolie, Jason Roberts, Steven Wallis +4
    JAC-Antimicrobial ResistancePeer-reviewedCC BY 4.0Full textPharmacology & toxicologyHAL
  4. Personalized Therapeutic Strategies in Glioblastoma: Bridging Molecular Markers and In Vivo Observations for Targeted Treatment
    Joaquin Fiallo Arroyo, Jose E. Leon-Rojas
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. From digital reminders to artificial intelligence–enabled understanding: can personalized treatment predictions improve therapeutic adherence?
    Valentin Goutaudier, Jean-Sébastien Hulot
    European Heart Journal. Cardiovascular PharmacotherapyPeer-reviewedCC BY 4.0Full text1 citedCardiovascular medicinePMC

Cite

BibTeXRIS
BibTeX
@article{bodei2026optimizing,
  title = {{Optimizing the Therapeutic Index: Sequential Intraarterial–Intravenous PRRT with Personalized Volumetric-Adjusted Dosing}},
  author = {Lisa Bodei and Etay Ziv and Audrey Mauguen and Pat Zanzonico and Diane Reidy and Adrian Gonzalez-Aguirre and Bae Chu and Jonathan Kuten and Nitya Raj and Heiko Schöder and Joseph A. O’Donoghue},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  month = nov,
  doi = {10.2967/jnumed.126.272710},
  url = {https://doi.org/10.2967/jnumed.126.272710},
}
RIS
TY  - JOUR
TI  - Optimizing the Therapeutic Index: Sequential Intraarterial–Intravenous PRRT with Personalized Volumetric-Adjusted Dosing
AU  - Lisa Bodei
AU  - Etay Ziv
AU  - Audrey Mauguen
AU  - Pat Zanzonico
AU  - Diane Reidy
AU  - Adrian Gonzalez-Aguirre
AU  - Bae Chu
AU  - Jonathan Kuten
AU  - Nitya Raj
AU  - Heiko Schöder
AU  - Joseph A. O’Donoghue
PY  - 2026
DA  - 2026/11/03
JO  - Journal of Nuclear Medicine
DO  - 10.2967/jnumed.126.272710
UR  - https://doi.org/10.2967/jnumed.126.272710
SN  - 0161-5505
SN  - 1535-5667
ER  -